New: Introducing the Finviz Futures Map

ProPhase Labs, Inc.

Contributing Author

Recent Articles by ProPhase Labs, Inc.

Sep-03	ProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025 PRPH GlobeNewswire
Aug-19	ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders PRPH GlobeNewswire
Aug-13	ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 PRPH GlobeNewswire
Aug-12	ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment PRPH GlobeNewswire
Aug-11	ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 PRPH GlobeNewswire
Jul-29	ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement PRPH GlobeNewswire
Jul-23	ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing PRPH GlobeNewswire
Jul-21	ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative PRPH GlobeNewswire
Jun-26	ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule PRPH GlobeNewswire
Jun-17	ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart Test in Detecting Esophageal Cancer PRPH GlobeNewswire
Jun-06	ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform PRPH GlobeNewswire
May-20	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 PRPH GlobeNewswire
May-13	ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 PRPH GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.